search
Back to results

Decoding and Modulating Affective Brain States

Primary Purpose

Rumination, Major Depressive Disorder, Anxiety

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Transcranial Magnetic Stimulation
Sponsored by
University of Pennsylvania
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Rumination focused on measuring TMS, rumination, depression, anxiety

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion criteria:

  1. 18-65 years old
  2. Right-handed
  3. Patient Health Questionnaire (PHQ-9 score) = or > than 10
  4. Comprehension of instructions in the English language.
  5. Capacity to provide informed consent and follow study procedures.
  6. Availability for the duration of the study.

Exclusion Criteria:

  1. Diagnosis of bipolar disorder (as PI discretion), schizophrenia or other psychotic disorder
  2. Recent use of psychoactive medications or substances as determined by investigators
  3. History of neurological disorder or traumatic brain injury (other than mild)
  4. Unable to have an MRI scan, or current or prior medical condition that could interfere with the collection or interpretation of MRI data
  5. Unable to receive or tolerate TMS
  6. Implanted devices, such as an aneurysm clip or cardiac pacemaker
  7. History of stroke, epilepsy, or brain scarring
  8. Pregnant, nursing, or trying to become pregnant (self-attestation alone)
  9. Otherwise determined by investigator to be unfit for study

Sites / Locations

  • University of PennsylvaniaRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Neuromodulation using the optimal rTMS stimulation frequency

Neuromodulation using the least optimal rTMS stimulation frequency

Arm Description

Through manipulation of brain state with a negative-affect task and using fMRI as the feedback signal, we aim to fine-tune repetitive Transcranial Magnetic Stimulation (rTMS) delivery to maximally impact the desired brain states in awake behaving study participants in a highly individualized manner (Visit 3: TMS/fMRI). The optimal rTMS stimulation frequency will be tested in a 3-day rTMS neuromodulation intervention.

We will compare the results of the optimal rTMS frequency neuromodulation with a separate 3-day neuromodulation session using the least optimal rTMS frequency, as determined by Visit 3: TMS/fMRI.

Outcomes

Primary Outcome Measures

Change in ruminative response scale (RRS) score after using the optimal rTMS stimulation frequency vs the least optimal rTMS stimulation frequency
By comparing the RRS score change pre/post rTMS of both neuromodulation sessions (Visits 4-6/7-9) we will see if our optimal rTMS stimulation frequency is more effective at improving clinical outcomes.

Secondary Outcome Measures

Full Information

First Posted
June 13, 2022
Last Updated
May 24, 2023
Sponsor
University of Pennsylvania
search

1. Study Identification

Unique Protocol Identification Number
NCT05437705
Brief Title
Decoding and Modulating Affective Brain States
Official Title
Decoding and Modulating Affective Brain States
Study Type
Interventional

2. Study Status

Record Verification Date
May 2023
Overall Recruitment Status
Recruiting
Study Start Date
April 21, 2023 (Actual)
Primary Completion Date
December 1, 2027 (Anticipated)
Study Completion Date
December 1, 2028 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Pennsylvania

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Generating personalized brain signatures of negative emotion along with personalized brain stimulation protocols to disrupt these patterns. We plan to use fMRI and muscle activity data to determine negative affect maps for each participant. We will then try a variety of patterned repetitive transcranial magnetic stimulation sequences while recording fMRI which will be the basis of two sessions of 3-day individualized brain stimulation designed to reduce negative affect.
Detailed Description
The study involves 9 visits and 4 optional visits. Visit 1 will consist of a consenting and extended screening visit. Visit 2 will involve a 1hour MRI scan and an assessment session. The MRI scan will include both structural and functional scans, facial electromyography (EMG) recordings, cognitive tasks, and multiple questionnaires.Visit 3 will be a 2-hour TMS/fMRI session, where the participant will engage in behavioral tasks while interleaved rTMS rounds are delivered at different excitatory frequencies. This scan will be used to determine the optimal stimulation frequency for the participant. During the Visits 4-6, participants will receive rTMS using either the optimal or least optimal rTMS stimulation frequency. They will also complete a worry induction or relaxation task before and after rTMS, with assessments in between. We will counterbalance whether do worry or relax first. After these visits there will be two optional MRI scans, one similar to Visit 2, and another similar to TMS/fMRI visit. After two weeks, the study Visits 7-9 will mirror the Visits 4-6 study visits, however the rTMS stimulation frequency used would be counterbalanced. The order of optimized and least-optimized frequencies will be counterbalanced across participants between Visit 4-6 and Visit 7-9 (i.e. half of the participants will receive stimulations of the two frequencies in one order, and the other half will receive stimulations of the two frequencies in the reverse order). After this second round of neuromodulation, the same optional visits will be repeated. These optional visits will examine brain and behavioral changes after each round of neuromodulation. After completing all procedures, participants will receive the study compensation. Payment procedures completed may be given earlier if participants withdraw from the study.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Rumination, Major Depressive Disorder, Anxiety
Keywords
TMS, rumination, depression, anxiety

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Model Description
All subjects will receive TMS using the optimized and least optimized frequencies, but the order is randomized and counterbalanced.
Masking
Participant
Masking Description
The study will use a single-blind design.
Allocation
Randomized
Enrollment
40 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Neuromodulation using the optimal rTMS stimulation frequency
Arm Type
Experimental
Arm Description
Through manipulation of brain state with a negative-affect task and using fMRI as the feedback signal, we aim to fine-tune repetitive Transcranial Magnetic Stimulation (rTMS) delivery to maximally impact the desired brain states in awake behaving study participants in a highly individualized manner (Visit 3: TMS/fMRI). The optimal rTMS stimulation frequency will be tested in a 3-day rTMS neuromodulation intervention.
Arm Title
Neuromodulation using the least optimal rTMS stimulation frequency
Arm Type
Active Comparator
Arm Description
We will compare the results of the optimal rTMS frequency neuromodulation with a separate 3-day neuromodulation session using the least optimal rTMS frequency, as determined by Visit 3: TMS/fMRI.
Intervention Type
Device
Intervention Name(s)
Transcranial Magnetic Stimulation
Intervention Description
Transcranial Magnetic Stimulation (TMS) is a non-invasive form of brain stimulation. TMS can influence activity in various brain regions, and it allows researchers to test or modify brain circuit communication. The MagPro X100* magnetic stimulator and Cool-B65 Butterfly Coil are FDA-approved for rTMS treatments of depression.
Primary Outcome Measure Information:
Title
Change in ruminative response scale (RRS) score after using the optimal rTMS stimulation frequency vs the least optimal rTMS stimulation frequency
Description
By comparing the RRS score change pre/post rTMS of both neuromodulation sessions (Visits 4-6/7-9) we will see if our optimal rTMS stimulation frequency is more effective at improving clinical outcomes.
Time Frame
Up to 4 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion criteria: 18-65 years old Right-handed Patient Health Questionnaire (PHQ-9 score) = or > than 10 Comprehension of instructions in the English language. Capacity to provide informed consent and follow study procedures. Availability for the duration of the study. Exclusion Criteria: Diagnosis of bipolar disorder (as PI discretion), schizophrenia or other psychotic disorder Recent use of psychoactive medications or substances as determined by investigators History of neurological disorder or traumatic brain injury (other than mild) Unable to have an MRI scan, or current or prior medical condition that could interfere with the collection or interpretation of MRI data Unable to receive or tolerate TMS Implanted devices, such as an aneurysm clip or cardiac pacemaker History of stroke, epilepsy, or brain scarring Pregnant, nursing, or trying to become pregnant (self-attestation alone) Otherwise determined by investigator to be unfit for study
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Almaris Figueroa-Gonzalez
Phone
215-746-6751
Email
almaris.figueroa-gonzalez@pennmedicine.upenn.edu
First Name & Middle Initial & Last Name or Official Title & Degree
Camille Blaine
Phone
215-746-3512
Email
camille.blaine@pennmedicine.upenn.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Desmond Oathes, PhD
Organizational Affiliation
Assistant Professor of Psychiatry
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Pennsylvania
City
Philadelphia
State/Province
Pennsylvania
ZIP/Postal Code
19104
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Almaris Figueroa-Gonzalez
Phone
215-746-6751
Email
almaris.figueroa-gonzalez@pennmedicine.upenn.edu
First Name & Middle Initial & Last Name & Degree
Camille Blaine
Phone
215-746-3512
Email
camille.blaine@pennmedicine.upenn.edu
First Name & Middle Initial & Last Name & Degree
Desmond J Oathes, PhD

12. IPD Sharing Statement

Learn more about this trial

Decoding and Modulating Affective Brain States

We'll reach out to this number within 24 hrs